Black race may be associated with worse overall survival in renal cell carcinoma patients

Harry Anastos(Icahn School of Medicine at Mount Sinai), Ketan K. Badani(Henry Ford Health System), Greg Gin(VA Long Beach Healthcare System), Alberto Martini(The University of Texas MD Anderson Cancer Center), David J. Paulucci(Mount Sinai Hospital), Alp Tuna Beksaç(Cleveland Clinic), Hiren V. Patel(Rutgers Cancer Institute), Nikhil Waingankar(Icahn School of Medicine at Mount Sinai), Jorge Daza(Icahn School of Medicine at Mount Sinai), John P. Sfakianos(Mount Sinai Medical Center)
Urologic Oncology Seminars and Original Investigations
September 17, 2020
10.1016/j.urolonc.2020.08.034
Cited by 13

Related Papers

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
|European Urology|2025|190
Hood Technique for Robotic Radical Prostatectomy—Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates
|European Urology|2020|158
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer
|European Urology|2019|144